Description of the medicine: Leacadin (Leacadinum)
LEACADIN (Leacadinum). 2-carbamoylaziridine.
White crystalline powder.
Easily soluble in water, moderately in alcohol.
The drug has an immunocorrective effect. In addition to the immunostimulating effect, it helps to increase the cytotoxicity of killer cells and monocytes, and inhibits the growth of tumors.
Leacadine is used in adults as an immunostimulating agent in combination therapy for cancer.
Enter intravenously at the rate of 100 - 300 mg / m 'daily for 10 15 days.
Immediately before use, dissolve the contents of the vial in 20-40 ml of isotonic sodium chloride solution.
If necessary, treatment with leacadin is repeated at 3-week intervals.
When using leacadin, nausea, vomiting, leukopenia, thrombocytopenia, and increased blood pressure are possible. In this case, reduce the dose or cancel the drug.
Leakadin is contraindicated in case of leukopenia (below 3 10 10 / l), thrombocytopenia (below 12 * 10 9 / l), gastric ulcer and duodenal ulcer, stage II – III hypertension, thrombophlebitis in the exacerbation phase.
Release form: lyophilized powder in vials of 0.1 and 0.5 g and vials of 0.1 g (Leacadinum lyophilisatum 0.1 - 0.5 pro injectionibus).
Storage: List B. In the dark place at a temperature of no higher than + 5 C.